123 related articles for article (PubMed ID: 37129994)
1. Radiologically enlarged cardiophrenic lymph nodes and CA-125 in relation to diaphragmatic carcinomatosis, surgical outcome, and overall survival in advanced ovarian cancer.
Plana A; Talo R; Wallengren NO; Pudaric S; Sartor H; Asp M
Acta Oncol; 2023 May; 62(5):451-457. PubMed ID: 37129994
[TBL] [Abstract][Full Text] [Related]
2. Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer.
Luger AK; Steinkohl F; Aigner F; Jaschke W; Marth C; Zeimet AG; Reimer D
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1092-1099. PubMed ID: 32112653
[TBL] [Abstract][Full Text] [Related]
3. The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC).
Asp M; Malander S; Wallengren NO; Pudaric S; Bengtsson J; Sartor H; Kannisto P
Arch Gynecol Obstet; 2022 Oct; 306(4):1235-1243. PubMed ID: 35235024
[TBL] [Abstract][Full Text] [Related]
4. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.
Kim TH; Lim MC; Kim SI; Seo SS; Kim SH; Park SY
Ann Surg Oncol; 2016 Apr; 23(4):1302-8. PubMed ID: 26714941
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival.
Mert I; Kumar A; Sheedy SP; Weaver AL; McGree ME; Kim B; Cliby WA
Gynecol Oncol; 2018 Jan; 148(1):68-73. PubMed ID: 29129390
[TBL] [Abstract][Full Text] [Related]
7. What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival.
Addley S; Asher V; Kirke R; Bali A; Abdul S; Phillips A
Eur J Surg Oncol; 2022 Dec; 48(12):2531-2538. PubMed ID: 35718677
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative Ultrasound-Guided Excision of Cardiophrenic Lymph Nodes in an Advanced Ovarian Cancer Patient.
Moro F; Uccella S; Testa AC; Scambia G; Fagotti A
Int J Gynecol Cancer; 2018 Nov; 28(9):1672-1675. PubMed ID: 30371564
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian Cancer: A Review.
Acs M; Piso P; Prader S
Anticancer Res; 2022 Jan; 42(1):13-24. PubMed ID: 34969704
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer.
Song S; Chen H; Ning G; Guo Y; Li X
Front Oncol; 2023; 13():1149139. PubMed ID: 37007136
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.
Garbi A; Zanagnolo V; Colombo N; Aletti G; Achilarre MT; Bocciolone L; Landoni F; Rizzo S; Biffi R; Maggioni A
Int J Gynecol Cancer; 2017 Jul; 27(6):1268-1273. PubMed ID: 28498236
[TBL] [Abstract][Full Text] [Related]
14. Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis.
Larish A; Mert I; McGree M; Weaver A; Sheedy S; Cilby W
Int J Gynecol Cancer; 2020 Apr; 30(4):504-508. PubMed ID: 31953350
[TBL] [Abstract][Full Text] [Related]
15. The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian Cancer.
Pinelli C; Morotti M; Casarin J; Tozzi R; Alazzam M; Mavroeidis VK; Soleymani Majd H
J Invest Surg; 2021 Jul; 34(7):756-762. PubMed ID: 31809609
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of CT detected enlarged cardiophrenic nodes in ovarian cancer patients.
Oommen I; Chandramohan A; Raji PS; Thomas A; Joel A; Samuel Ram T; Peedicayil A
Abdom Radiol (NY); 2021 Jan; 46(1):331-340. PubMed ID: 32577780
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Peritoneal Cancer Index After Complete Cytoreductive Surgery in Advanced Ovarian Cancer.
Asp M; Malander S; Bengtsson J; Sartor H; Kannisto P
Anticancer Res; 2022 May; 42(5):2541-2551. PubMed ID: 35489749
[TBL] [Abstract][Full Text] [Related]
18. Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.
Prader S; Vollmar N; du Bois A; Heitz F; Schneider S; Ataseven B; Bommert M; Waltering KU; Heikaus S; Koch JA; Alesina PF; Traut A; Harter P
Gynecol Oncol; 2019 Jan; 152(1):76-81. PubMed ID: 30463683
[TBL] [Abstract][Full Text] [Related]
19. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
[TBL] [Abstract][Full Text] [Related]
20. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Iyer RB; Zhou Q; Iasonos A; Denesopolis J; Zivanovic O; Long Roche KC; Sonoda Y; Coleman RL; Abu-Rustum NR; Hricak H; Chi DS
Gynecol Oncol; 2017 Apr; 145(1):27-31. PubMed ID: 28209497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
